섹션 설정
OUR COMPANY
Company Introduction
OUR COMPANY
Company Introduction
2022
01 Selected BIG3 Innovation Startup Package by the Ministry of SMEs and Startups
03 Certification of Inno-Biz
04 Selected to be a 2022 regular membership(Global) of Shinhan Square Bridge Incheon
05 Attracted investment from Korea Venture Fund
Certification of Small Giant Corporate by the Ministry of Employment and Labor
2021
01 Headquarters relocation (Incheon Startup Park)
04 Licensed-out RCI001 to Hanlim pharmaceutical Co. for domestic rights
07 RCI002 PCT and US Patent Application
08 RudaCure U.S.A. Establishment of U.S. Corporate
09 Selected to be part of Bio I-Corps Program by the Minister of Science & Technology
Attracted investments from Y&Archer and other individual investors
10 Two trademark registrations
11 Venture Investment Association (CKD Startup Investment) to attract investment
12 RCI002 Domestic Patent Registration
Atopic dermatitis/AMD before extension of applicability
Full-time Toxicity and Effectiveness Test Research Service Expansion
Please enter 8 to 20 characters including English, numbers, and special characters.
Company Name RudaCure Co., Ltd
CEO Yong Ho Kim | CPO Seunghoon Kim
Location HQ: R316, InstarⅠ, 204, Convensia-daero, Yeonsu-gu, Incheon, Republic of Korea
Research Institute : R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
US Office 40W, 37th St. Suite 801 New York, NY 10018
Corportate registration number 548-86-00995
COPYRIGHT (C) LOGO. All Rights reserved
Company Name RudaCure Co., Ltd | CEO Yong Ho Kim | CPO Seunghoon Kim
Location
HQ R316, InstarⅠ, 204, Convensia-daero, Yeonsu-gu, Incheon, Republic of Korea
Research Institute R302, BRC1, 9, Songdomirae-ro, Yeonsu-gu, Incheon, Republic of Korea
Seoul Office R1001, 145, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea
US Office 40W, 37th St. Suite 801 New York, NY 10018
Corportate registration number 548-86-00995
COPYRIGHT (C) RUDACURE. All Rights reserved